Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

P704P Inhibitors

However, to provide a general insight into how inhibitors for a novel protein target might be conceptualized, one can consider the typical process involved in inhibitor development. If P704P were a newly identified protein implicated in a critical biological pathway, the creation of inhibitors would start with a comprehensive understanding of the protein's structure-function relationship. Researchers would employ a variety of analytical techniques, such as X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy, to elucidate the protein's three-dimensional structure. This information would reveal potential binding sites for small molecules or other types of inhibitory compounds. High-throughput screening of chemical libraries could then be conducted to identify initial hits that exhibit inhibitory activity against P704P.

Following the discovery of lead compounds, medicinal chemists would engage in the optimization of these molecules to improve their specificity and potency as P704P inhibitors. This would involve the systematic modification of the chemical structure of these molecules, guided by structure-activity relationship (SAR) studies. Such studies would help in understanding how different chemical groups within the molecules contribute to their ability to bind to and inhibit P704P. Computational modeling and simulation would complement experimental approaches, providing predictive insights into how these modifications might affect the interaction between the inhibitors and P704P. The goal would be to produce high-affinity inhibitors that can selectively target P704P without interacting with other proteins. Throughout this process, the physicochemical properties of the inhibitors, such as solubility, stability, and permeability, would also be finely tuned to ensure that they can effectively reach the site of P704P within the biological context. This meticulous process of inhibitor development involves a multidisciplinary approach, combining elements of computational chemistry, synthetic chemistry, and molecular biology to achieve precise modulation of the protein's activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Sirolimus inhibits mTOR, a kinase involved in the regulation of protein synthesis and cell proliferation, potentially reducing expression of proteins like POTE family members.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine incorporates into RNA and DNA, leading to demethylation and disruption of nucleic acid function, which may inhibit gene expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

Decitabine is a DNA methyltransferase inhibitor that leads to DNA demethylation and can alter gene expression, potentially affecting the POTE family members.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Vorinostat inhibits histone deacetylases (HDACs), which can change gene expression patterns, possibly impacting POTE family protein levels.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
19
(3)

Sodium butyrate is an HDAC inhibitor that can induce hyperacetylation of histones, leading to changes in gene expression.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, which can affect protein folding and stability, potentially leading to reduced protein levels.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Doxorubicin intercalates into DNA, causing breaks and inhibiting macromolecular biosynthesis, which may decrease gene expression.

Homoharringtonine

26833-87-4sc-202652
sc-202652A
sc-202652B
1 mg
5 mg
10 mg
$51.00
$123.00
$178.00
11
(1)

Homoharringtonine inhibits protein synthesis at the initial elongation step, which can decrease the levels of proteins such as those from the POTE family.

Ellipticine

519-23-3sc-200878
sc-200878A
10 mg
50 mg
$142.00
$558.00
4
(1)

Ellipticine intercalates into DNA and inhibits topoisomerase II, which can suppress transcription and reduce protein synthesis.

Mycophenolic acid

24280-93-1sc-200110
sc-200110A
100 mg
500 mg
$68.00
$261.00
8
(1)

Mycophenolic acid inhibits inosine monophosphate dehydrogenase, leading to depletion of guanine nucleotides and potentially affecting RNA and DNA synthesis.